Medical Data Vision Co (TSE:3902) Stock Based Compensation: 円0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3902 Medical Data Vision Co Ltd TSE:3902
56 GF Score
Price 円1,684.00
GF Value 円657.61
! 7 Warning Signs
View Full Analysis

What is Medical Data Vision Co Stock Based Compensation?

Medical Data Vision Co TSE:3902 56 Stock Based Compensation is 円0 Mil as of Dec. 2025. GuruFocus rates TSE:3902 with a GF Score™ of 56/100 and a GF Value™ of 円657.61. The stock has 7 warning signs investors should review.

Medical Data Vision Co's Stock Based Compensation for the six months ended in Dec. 2025 was 円0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was 円0 Mil.

Medical Data Vision Co Stock Based Compensation Related Terms

Medical Data Vision Co Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Medical Data Vision Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Data Vision Co Stock Based Compensation Chart

Medical Data Vision Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.87 0.00 0.00 0.00 0.00

Medical Data Vision Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:3902
56GF Score
Medical Data Vision Co Ltd TSE:3902
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Data Vision Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

What does a Stock Based Compensation of 円0 Mil mean?
Medical Data Vision Co (TSE:3902) has a Stock Based Compensation of 円0 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medical Data Vision Co and its competitors.
Is Medical Data Vision Co's Stock Based Compensation too high?
Medical Data Vision Co's current Stock Based Compensation is 円0 Mil. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's Stock Based Compensation compare to VEEV and TEM?
Medical Data Vision Co's Stock Based Compensation of 円0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Medical Data Vision Co and its competitors. Medical Data Vision Co's current Stock Based Compensation is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current Stock Based Compensation of 円0 Mil. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current Stock Based Compensation is 円0 Mil. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current Stock Based Compensation is 円0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued. The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.

Key valuation signals for TSE:3902:

  • Stock Based Compensation: 円0 Mil
  • GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical Data Vision Co Business Description

Address 7, Kandamitoshirocho, Chiyoda-ku, Tokyo, JPN, 101-0053
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score

Get the complete analysis for TSE:3902

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,684.00
Price
円657.61
GF Value